Skip to Content

Mecasermin Pregnancy and Breastfeeding Warnings

Mecasermin is also known as: Increlex

Medically reviewed on May 25, 2016.

Mecasermin Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: C

Recommendation:
-Women of childbearing potential should have a negative pregnancy test before treatment, and use adequate contraception during treatment.

Animal studies did not show teratogenicity, but did show an increase in fetal death. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Mecasermin Breastfeeding Warnings

Use is not recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

See references

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. "Product Information. Increlex (mecasermin)." Tercica Inc, Brisbane, CA.

References for breastfeeding information

  1. "Product Information. Increlex (mecasermin)." Tercica Inc, Brisbane, CA.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide